🔓 Unlock the full profile of Manish Gupta (Indegene), including verified contact details, financial insights, and professional associations.

See Manish Gupta Full Profile

---

Below are the ✅ Verified Contact Details to help you connect directly:

Email: man*****@ind******.com

Mobile: 68168*****

Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)

Key Insights You Should Know About This Individual

• Manish Gupta is the Co-founder and Chief Executive Officer of Indegene, a company founded in February 2000 that specializes in addressing complex challenges in healthcare through the integration of analytics, technology, operations, and medical expertise.
• Under Gupta's leadership, Indegene has grown significantly and now serves over 85 global customers across various sectors, including biotech companies, medical device manufacturers, health plans, and accountable care organizations.
• Indegene offers a comprehensive portfolio of solutions in medical, marketing, risk, healthcare quality, clinical effectiveness, and care management, contributing to improved revenue and productivity for clients.
• Gupta has played a pivotal role in establishing Indegene's global presence with offices in the United States, United Kingdom, China, India, and Australia, enabling the company to leverage a diverse talent pool and global healthcare knowledge.
• The company is positioned as a leader in digital transformation and customer engagement within the life sciences sector, addressing crucial elements such as healthcare cost reduction and health outcomes improvement.
• Gupta's journey and insights were shared in a candid interview format during a fireside chat with Ashish Dhawan at Ashoka University, highlighting personal experiences and challenges faced while building Indegene.
• Indegene employs approximately 5,798 staff members, showcasing its capacity to manage large-scale operations and project demands effectively.
• Gupta's leadership emphasizes innovation in healthcare management consulting, ensuring that Indegene stays at the forefront of industry trends and challenges.

Current appointment

CIN/LLP	Company Name	Designation	Appointment Date
U73100KA1998PLC102040	Indegene Limited	Whole-time director	11 Feb 2000

, Previous appointment

CIN/LLP	Company Name	Designation	Appointment Date | End Date
U24232KA2006PTC041018	Inexios Pharmaceuticals Private Limited	Director	23 Nov 2006| 03 March 2011